Investor Relations

Medizone International, Inc. Shareholder Information
Medizone International, Inc. trades under the ticker symbol “MZEI” Over-the-Counter and is fully reporting.

Additionally, Medizone International, Inc. is traded electronically OTCQB: MZEI.

Medizone International, Inc. (OTCBB: MZEI)
4000 Bridgeway,
Suite 401, Sausalito, CA 94965
Telephone: 415-331-0303
Investor Relations: 415-331-0202

Medizone International, Inc. (MZEI) Traded:

Over the Counter Bulletin Board (OTCBB) MZEI

Electronically OTCQB: MZEI

The OTCBB is a regulated electronic trading service offered by the National Association of Securities Dealers (NASD) that shows real time quotes, last-sale prices and volume information for over-the-counter (OTC) equity securities. Companies listed on this exchange are required to file current financial statements with the Securities and Exchange Commission (SEC).

Common Stock Outstanding:

March 31, 2014, there were 324,076,274 shares of common stock issued and outstanding.

Transfer Agent:
American Stock Transfer & Trust
59 Maiden Lane
New York, New York  10038
Phone: 212-936-5100

Certified Public Accountant:
HJ & Associates, LLC
50 West Broadway, Suite 600
Salt Lake City, Utah 84101-2039

 

Investor Relations Contact:

John Pentony
415-331-0202
j.pentony@medizoneint.com

Medizone Shareholder Alert

It has been brought to our attention that it has become increasingly difficult to deposit certificates evidencing free trading registered shares of OTCBB traded companies into retail brokerage accounts with many of the larger, well recognized brokerage firms.

Medizone and other key industry professionals, within the legal and financial industry, are taking a pro-active stance on this issue with the SEC and FINRA. In that regard, we have representitives taking part in an upcoming SEC meeting in Washington D.C. to address the current situation.

In this current regulatory environment, the large firms will act as Market Makers in OTCBB securities, such as MZEI, and will typically allow buying and selling of these same securities by retail account holders, but are making it difficult if not impossible for shareholders to deposit certificates evidencing fully registered shares into their client accounts.

In our opinion this is an unfair, illogical situation that clearly harms both issuers and shareholders and needs to be corrected.

Until FINRA and/or the SEC takes corrective action, we feel obligated to assist our shareholders in finding an effective and efficient solution for managing their accounts without undo hassle. Therefore, as a first step, we recommend that you contact your brokerage firm to discuss their policies on accepting shares of MZEI for deposit before delivering certificates to them.

 

If you are experiencing problems with a broker/dealer in connection with the sale or trading of securities on your behalf, you may also contact the Financial Industry Regulatory Authority (FINRA)’s Office of the Ombudsman toll free at (888) 700-0028 or by mail at FINRA Ombudsman, P.O. Box 9492, Gaithersburg, MD 20898-9492. Additional information is available on the FINRA website, www.finra.org.

 

Contact:

Medizone International, Inc. (MZEI.OB)

4000 Bridgeway, Suite 401
Sausalito, CA 94965

Telephone: 415-331-0303

Email: operations@medizoneint.com

Investor Relations:

John Pentony

Investor Relations
Medizone International, Inc.

Telephone: (415) 331-0202

E: j.pentony@medizoneint.com

Media Contact:

Gary Hanauer

Media Relations
Medizone International, Inc.

Telephone: (510) 686-1238

E: GarHan@aol.com